(Press-News.org) A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Principal investigator Edith Perez, MD, Mayo Clinic in Florida, presented the results of the first ever randomized trial of trastuzumab-DM1 (T-DM1) as a first-line treatment for metastatic breast cancer.
T-DM1 is the first of a new type of cancer medicine known as an antibody-drug conjugate. It binds together two existing cancer drugs with the aim of delivering both drugs specifically to cancer cells: trastuzumab, a monoclonal antibody that targets cells that overproduce the protein HER2; and DM1, a chemotherapy agent that targets microtubules.
"This is the first ever presentation of an anti-HER2 antibody-drug conjugate used as first-line therapy for patients with advanced breast cancer," said Professor Perez. "We are encouraged by the results. The study demonstrated that T-DM1 has very good anti-tumor activity as well as much lower toxicity when evaluated side by side to the older 'standard'."
T-DM1 has shown promising activity in preclinical studies. Other clinical trials have also shown it to be effective in patients whose advanced cancer has not responded to other treatments. "This trial represents the logical step --moving the drug up to patients with newly diagnosed HER2-positive metastases," Prof Perez said.
In the trial, researchers randomly assigned 137 women to treatment with either trastuzumab plus the chemotherapy drug docetaxel, or T-DM1. All participants had HER2-positive metastatic cancer, with no prior chemotherapy for their metastatic disease.
After a median of approximately 6 months of follow-up, the researchers found an overall response rate of 48% in patients administered T-DM1, compared to 41% in the trastuzumab plus docetaxel arm. Importantly, the rates of clinically relevant adverse events were significantly lower in the T-DM1 arm (37%) compared to the rate in women given traztuzumab plus docetaxel (75%).
This trial is ongoing and the positive outcomes are generating enthusiasm for a larger Phase-III trial which is now underway. "This trial is named MARIANNE, and it evaluates taxane plus trastuzumab against T-DM1 as administered in this study, with a third option being T-DM1 plus pertuzumab, another novel anti-HER2 agent," said Prof Perez. "I feel privileged to continue our collaborative work to help bring new and better therapeutic options for patients."
The results are important for two reasons, commented Dr Fabrice André from Institut Gustave Roussy in Villejuif, France.
"Firstly, they confirm that in coming years chemotherapy could be replaced by a less toxic compound. Indeed, in the present study, the rates of serious adverse events were much lower in patients given T-DM1 compared to the chemotherapy arm. These results suggest that, with the same efficacy, T-DM1 could dramatically reduce the toxicities related to chemotherapy."
The second important implication of this study is that it proves the concept that linking a monoclonal antibody to a cytotoxic drug leads to an anticancer effect. "This could have several implications beyond drugs that target HER2," Dr André said.
INFORMATION:
END
NASHVILLE, Tenn.—We know that casting a ballot in the voting booth involves politics, values and personalities. But before you ever push the button for your candidate, your brain has already carried out an election of its own to make that action possible. New research from Vanderbilt University reveals that our brain accumulates evidence when faced with a choice and triggers an action once that evidence reaches a tipping point.
The research was published in the October issue of Psychological Review.
"Psychological models of decision-making explain that humans gradually ...
Saranac Lake, N.Y. – A billion people living in underdeveloped areas around the world are infected with parasitic helminthes, worms that survive by residing in and feeding on their hosts. These infestations can cause chronic intestinal (and occasionally systemic) illnesses leading to long-term disability. Irah King and Markus Mohrs, biomedical researchers at the Trudeau Institute, are investigating illnesses caused by these gut-dwelling worms in an effort to decipher how immune cells send and receive signals that determine the specific immune response to mount.
In a study ...
TEMPE, Az. - An international team of scientists, exploiting pioneering techniques at Arizona State University, has taken a significant step toward unlocking the secrets of oxygenation of the Earth's oceans and atmosphere.
Evolution of the Earth's multitude of organisms is intimately linked to the rise of oxygen in the oceans and atmosphere. The new research indicates that the appearance of large predatory fish as well as vascular plants approximately 400 million years ago coincided with an increase in oxygen, to levels comparable to those we experience today. If so, ...
Educational policy is controversial: positions on achievement gaps, troubled schools and class size are emotionally charged, and research studies often come to very different conclusions.
But what if there was a new way of looking at the problem -- a way that treats education as a complex system (taking into account all interactions) and uses computer modeling and network analysis to provide a comprehensive look at the outcomes of policy choices?
Researchers at Northwestern University's McCormick School of Engineering and Applied Science and School of Education and ...
The sudden death of bee colonies since late 2006 across North America has stumped scientists. But today, researchers may have a greater understanding of the mysterious colony collapse disorder, said a Texas Tech University biologist.
Shan Bilimoria, a professor and molecular virologist, said the bees may be taking a one-two punch from both an insect virus and a fungus, which may be causing bees to die off by the billions.
Bilimoria is part of a team of researchers searching for the cause of the collapse. Led by research professor Jerry Bromenshenk from the University ...
COLUMBIA, Mo. – Diagnostic ultrasounds are the most widely used medical tests in the world. Though the technology is more than 50 years old, scientists continue to discover new uses for it, ranging from more targeted cancer treatments to liposuction. As the technology becomes more complex, a sonographer's skill level is even more important. Now, researchers at the University of Missouri may have found one of the keys to becoming a successful sonographer: spatial ability.
Doug Clem, clinical assistant professor of MU's diagnostic ultrasound program in the MU School ...
NASA's James Webb Space Telescope continues to make significant progress, successfully completing a series of sunshield vent tests that validate the telescope's sunshield design.
"While adequate venting is a design consideration for all spaceflight hardware, this was a particularly unique challenge for the sunshield given the large volume of trapped air in the membrane system at launch," said Keith Parrish, Webb telescope sunshield manager at NASA's Goddard Space Flight Center in Greenbelt, Md. "From the beginning of its development venting features have been a critical ...
A woman's race/ethnicity and socioeconomic status impact whether health care providers recommend one of the most highly effective forms of contraception, a UCSF study confirms. The results also indicate that the interaction of both factors plays a role in clinicians' decisions.
Recommendations by health care providers previously have been found to vary by patients' race and socioeconomic status, contributing to health disparities, according to the researchers. The team investigated the effect of these factors on recommendations for contraception.
Study results appear ...
When people are rejected by peers, they often lash out. In children, that aggression occasionally takes horrifying directions, leading to school shootings or other deadly acts. Researchers in the Netherlands found that some children are more likely than others to lash out in response to acute peer rejection: children who already feel like outcasts.
"It was inspired by the fact that we had these school shootings and wondered what the most important feature of these kids could be," says Albert Reijntjes of Utrecht University, who cowrote the study with five other psychological ...
RICHMOND, Va. (Oct. 8, 2010) – An international team of researchers has discovered a new class of highly electronegative chemical species called hyperhalogens, which use superhalogens as building blocks around a metal atom. The new chemical species may have application in many industries.
Researchers from Virginia Commonwealth University, McNeese State University in Lake Charles, La., and the University of Konstanz in Germany report their discovery in the Oct. 6 international chemistry journal Angewandte Chemie International Edition. The journal designated the paper as ...
